GNDs with questionable or no response to antiparkinsonian medication in most cases were Rett syndrome, Dravet syndrome (SCN1A), phosphoglycerate kinase deficiency, dystonia 16, Leigh syndrome, and Menkes disease. This evidence concerns the gene SCN1A and Leigh syndrome.